We are live on ! Find out more
EBMT icon

Eagle Bancorp Montana

18 hedge funds and large institutions have $12.5M invested in Eagle Bancorp Montana in 2013 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

29% more funds holding

Funds holding: 1418 (+4)

16% more capital invested

Capital invested by funds: $10.7M → $12.5M (+$1.75M)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
18
Holders Change
+4
Holders Change %
+28.57%
% of All Funds
0.52%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
1
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change

EBMT Hedge Fund Activity: Q4 2013 in Review

18 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Eagle Bancorp Montana (EBMT) for Q4 2013, worth a combined $12.5M — up 16% from $10.7M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new EBMT positions and 3 closed out — a net gain of 4 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Glacier Peak Capital, opening a new position worth an estimated $2.54M. The largest seller was Maltese Capital Management, exiting entirely with an estimated $2.75M sold.

  • 18 institutional investors held Eagle Bancorp Montana (EBMT) as of Q4 2013, up from 14 in Q3 2013.
  • Funds reported $12.5M of Eagle Bancorp Montana stock for Q4 2013, up 16% quarter-over-quarter.
  • 7 funds opened new Eagle Bancorp Montana positions in Q4 2013 and 3 closed out, a net change of +4 holders.
  • The largest Eagle Bancorp Montana buyer in Q4 2013 was Glacier Peak Capital, an estimated $2.54M added.
  • The largest Eagle Bancorp Montana seller in Q4 2013 was Maltese Capital Management, an estimated $2.75M sold.

Based on aggregated 13F filings for Q4 2013.